We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Events

27 Jan 2025 - 30 Jan 2025
15 Feb 2025 - 17 Feb 2025

Active Spine Robotics and Navigation Platform Returns Control to Surgeon's Hands

By HospiMedica International staff writers
Posted on 05 Aug 2024
Print article
Image: The VELYS SPINE dual-use robotics and standalone navigation platform has received U.S. FDA 510(k) clearance (Photo courtesy of DePuy Synthes)
Image: The VELYS SPINE dual-use robotics and standalone navigation platform has received U.S. FDA 510(k) clearance (Photo courtesy of DePuy Synthes)

A dual-use robotics and standalone navigation platform for use in planning and instrumenting spinal fusion procedures in the cervical, thoracolumbar, and sacroiliac spine can help surgeons tackle their most complex challenges.

Johnson & Johnson MedTech (New Brunswick, NJ, USA) has announced that DePuy Synthes (Raynham, MA, USA), The Orthopedics Company of Johnson & Johnson, is launching a proprietary dual-use robotics and standalone navigation platform developed in collaboration with eCential Robotics (Grenoble, France). The system is intended for use in planning and instrumenting spinal fusion procedures in the cervical, thoracolumbar, and sacroiliac spine.

This new spine technology was designed to help surgeons tackle their most complex challenges. The VELYS SPINE system is dual use, meaning it features both a standalone navigation and an active robotics platform that can enable surgeon flexibility in their approach and plans. Active robotics allows for surgical guidance tailored to surgeon preference. The distinctive features and capabilities of active robotics technology are set to establish a new standard in spine surgical care.

The VELYS SPINE system is designed to address the uniquely complex needs of spine surgeons and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The system offers a customizable experience with pathology-specific workflows, aided by capabilities such as VELYS ADAPTIVE TRACKING TECHNOLOGY and VELYS Trajectory Assistance. It will be used with the DePuy Synthes core Spine portfolio of products, including the TriALTIS Spine System and Navigation Enabled Instruments, the SYMPHONY Occipito-Cervico-Thoracic (OCT) System, VIPER PRIME System, and EXPEDIUM VERSE Systems.

"We are shaping the next frontier of orthopedic innovation with a relentless focus on digital advancements and excellence in the field of surgical robotics and navigation. Our dedication extends to enhancing patient care through significant strides in spine surgery," said Aldo Denti, Company Group Chair, DePuy Synthes. "This is a major step in growing our VELYS Portfolio and in our commitment to supporting spine surgeons and their patients with advanced tools."

"Today's landscape of enabling technologies features first-generation robotics systems that may face challenges in adapting to individual surgeon needs," said Russell Powers†, Worldwide President, Spine, DePuy Synthes. "We recognize the urgent need for innovative solutions that offer new ways to engage with enabling technologies, returning control to surgeon's hands. We believe that the unique features and capabilities of active robotics technology will set a new standard in surgical care for spine patients everywhere."

Related Links:
Johnson & Johnson MedTech
DePuy Synthes
eCential Robotics

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Monitor Cart
Tryten S5
New
Medical-Grade POC Terminal
POC-821

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.